https://pittplusme.org/study/1992
The CAHtalyst Study
We're sorry. This study is closed and no longer recruiting participants.
STUDY BASICS
Have you been diagnosed with congenital adrenal hyperplasia (CAH)? You may be able to participate in a study to assess if a study drug called crinecerfont is effective in lowering the daily glucocorticoid dose that CAH patients need to control symptoms. Participation will last about 20 months and includes 21 study visits. Compensation is provided. Travel reimbursement may also be provided.
IRB: 20200122
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecerfont (NBI-74788) in Adult Subjects with Classic Congenital Adrenal Hyperplasia, Followed by Open-Label Treatment
AGE:
18 and up
DURATION:
Up to 20 months
VISITS:
21 (some may be completed at home)
LOCATION:
UPMC Children’s Hospital of Pittsburgh - Lawrenceville
COMPENSATION:
$100 per completed study visit; travel reimbursement may be provided
SHARE STUDY
